PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemistry, Columbia University, New York, NY, 10027, USA.\', \'Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY, 10032, USA.\', \'Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, 10032, USA.\', \'Department of Biological Sciences, Columbia University, New York, NY, 10027, USA.\', \'Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, 10032, USA.\', \'Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA.\', \'Sulzberger Columbia Genome Center, Columbia University, New York, NY, 10032, USA.\', \'Medical Scientist Training Program, Columbia University Irving Medical Center, New York, NY, 10032, USA.\', \'Waters Corporation, 34 Maple Street, Milford, MA, 01757, USA.\', \'Department of Pharmacology and Molecular Therapeutics, Columbia University Irving Medical Center, New York, NY, 10032, USA.\', \'Department of Biochemistry, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.\', \'Institute for Antiviral Research, Utah State University, Logan, UT, 84322, USA.\', \'Department of Chemistry, Columbia University, New York, NY, 10027, USA. tr2504@columbia.edu.\', \'Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA. ac4304@cumc.columbia.edu.\', \'Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY, 10032, USA. dh2994@cumc.columbia.edu.\', \'Department of Chemistry, Columbia University, New York, NY, 10027, USA. bstockwell@columbia.edu.\', \'Department of Biological Sciences, Columbia University, New York, NY, 10027, USA. bstockwell@columbia.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-022-29413-2
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 35393402
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all